*** LIVE ***

If the NIH and JDRF have given Diatech Diabetes the nod through funding…should this company be on your radar? SmartFusion™ is an infusion set failure detection system licensed as a SaaS algorithm to infusion device manufacturers.

“Deep Dive” or uncut version of our video podcast. Drs Jeff Brown and Jeff Cole interview Diatech Diabetes founders John Wilcox and Luis Blanco. Diatech Diabetes is a medical device company committed to changing the way infusion set failure detection is done with their infusion set failure detection system, SmartFusion™. This is accomplished with a combination of real time data analysis and machine learning.

SmartFusion™, is an infusion set failure detection system licensed as software-as-a-service to infusion device manufacturers. SmartFusion™ is an algorithm designed specifically for insulin (and other ambulatory drug delivery) pumps to detect different types of infusion failures not currently detected by insulin pumps on the market.


Would this bring value to your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion.

Sign up today!   https://mergemedical.community.forum/


DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.